10/25/2022
Semaglutide was added to the Obesity Canada Guidelines this week.
This can have implications if you have received an ozempic prescription and were denied by your insurance company. You can try contacting them again today and letting them know that it is both approved by Health Canada and recommended by Obesity Canada.
The link below has more details.
Emerging research captured in revised chapters summarizing evidence for medical nutrition therapy and pharmacotherapy EDMONTON, October 21, 2022 – Canadian healthcare professionals who support patients living with obesity now have up-to-date information on the latest evidence for two important obe...